Triton Systems is a Global Business Venture company that successfully launches innovative products and solutions in emerging markets worldwide. We invest in new technologies through in-house incubation and external partnerships – creating thriving businesses from novel ideas.
Triton commercializes innovative technologies and transforms them into successful businesses. From cancer treatment to flame retardant plastic to waste water management, we impact global markets creating $3.8 Billion in shareholder value.
Aduro Biotech (Aduro), a Triton launched company formed in 2010, stays at the forefront of discovery, development and commercialization of immunotherapies, alone or in combination; that make transformative advances in the treatment of challenging diseases.
FRX Polymers, Inc.
FRX Polymers, Inc., a (formed by Triton in 2007) manufactures Nofia® polyphosphonates - fire resistant plastics. Nofia products are fully transparent, high flowing and, due to their high phosphorus content, are inherently flame retardant.
With several global innovation awards and a strong scientific background, Emefcy is at the forefront of the next generation of wastewater treatment.
Key to our process is to research, identify and incubate emerging technologies that are in line with our strategic market focus. Through our in-house incubation operations or through outside partnerships and adopted technologies, we provide market driven solutions that effect the world around us. Emerging technologies include:
Featured Incubated Products
A Plug and Play ‘Sensitivity Amplifier’ that enables chemical sensors for threat and contraband detection.
MEMS Sensors & Manufacturing
Triton designs, engineers and manufactures MEMS-based sensors and other devices for industrial, medical and defense applications.
(Fiber Reinforced Aluminum)
Triton FRA Composites is a fiber reinforced aluminum composite that offers light weight and high strength alternatives to heavy steel for bearing applications.
Triton Systems Hires New Executive Vice President
Will focus on commercializing emerging technologies
Triton has hired Dr. Jack Salerno as its new Executive Vice President. In this role, he will be responsible for accelerating commercialization of technology developed by the company.
Aduro Biotech Announces First Patient Dosed in Combination Clinical Trial of CRS-207 and Epacadostat to Treat Ovarian Cancer
BERKELEY, Calif., March 24, 2016 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (Nasdaq:ADRO) today announced that the first patient has been dosed in SEASCAPE, the Phase 1/2 clinical study designed to evaluate the safety, tolerability and preliminary efficacy of CRS-207, Aduro’s lead listeria-based immunotherapy construct (LADD), in combination with epacadostat (INCB24360), Incyte Corporation’s (Nasdaq:INCY) selective IDO1 inhibitor, in patients with ovarian cancer.
FRX Polymers Nofia Flame Retardants featured in Specialty Chemicals Highlights
New Article in Specialty Chemicals Highlights Advantages of Polymeric Flame Retardants (Page 34).
Emefcy Group Limited (ASX: EMC) Announces Signing Of First International Contract
Melbourne, Australia and Caesarea, Israel: The Directors of Emefcy Group Limited (ASX: EMC) are pleased to announce the signing of its first international contract for a SABRE-based wastewater treatment plant in Saint Thomas, U.S. Virgin Islands. When complete, the plant will provide the first reference site for customers in the Americas, including those interested in committing to contracts to buy water instead of paying to build and operate a SABRE system.